Open Access. Powered by Scholars. Published by Universities.®
- Publication
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Is There A Difference Between Burn Patients Treated With Topical Mafenide Acetate Before And During Covid-19?, Morgan Anderson, Sigrid A. Blome-Eberwein Md
Is There A Difference Between Burn Patients Treated With Topical Mafenide Acetate Before And During Covid-19?, Morgan Anderson, Sigrid A. Blome-Eberwein Md
Research Scholars
No abstract provided.
Use Of Botulinum Toxin A To Treat Chemotherapy-Induced Raynaud's Phenomenon., Thrisha K Potluri, Frank G Lee, Ethan Song, Sean J. Wallace Md, Nathan F. Miller Md
Use Of Botulinum Toxin A To Treat Chemotherapy-Induced Raynaud's Phenomenon., Thrisha K Potluri, Frank G Lee, Ethan Song, Sean J. Wallace Md, Nathan F. Miller Md
Department of Surgery
Raynaud's phenomenon (RP) is a vasospastic disorder of the digital blood vessels leading to pain, paresthesias, and pallor in response to cold or stress. RP can develop secondary to a number of pathologies or factors, including the use of chemotherapy agents. Typical first-line therapies for secondary RP may be contraindicated in patients with certain comorbidities. Here, we discuss a case in which botulinum toxin A (BTX-A) was used to treat chemotherapy-induced RP in a patient with non-small cell lung cancer (NSCLC). We provide a review of the existing literature on the clinical course and treatment modalities, including the use of …